Abbott India
- Advice
- Hold
Abbott India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Abbott India
Start SIPAbbott India Investment Rating
-
Master Rating:
-
Abbott India has an operating revenue of Rs. 5,265.35 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 22% is great, ROE of 28% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1,326 | 1,379 | 1,304 | 1,255 |
| Operating Expenses Qtr Cr | 1,010 | 1,036 | 1,034 | 961 |
| Operating Profit Qtr Cr | 316 | 343 | 270 | 294 |
| Depreciation Qtr Cr | 18 | 17 | 17 | 17 |
| Interest Qtr Cr | 4 | 4 | 4 | 5 |
| Tax Qtr Cr | 88 | 90 | 70 | 81 |
| Net Profit Qtr Cr | 247 | 266 | 206 | 211 |
Abbott India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- 20748.29
- 50 Day
- 20736.38
- 100 Day
- 20488.95
- 200 Day
- 19871.9
- 20 Day
- 20574.78
- 50 Day
- 20920.23
- 100 Day
- 20718.59
- 200 Day
- 19728.57
Abbott India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 21431.87 |
| Second Resistance | 21575.89 |
| Third Resistance | 21731.77 |
| RSI | 64.46 |
| MFI | 65.97 |
| MACD Single Line | -20.3 |
| MACD | 130.09 |
| Support | |
|---|---|
| First Resistance | 21131.97 |
| Second Resistance | 20976.09 |
| Third Resistance | 20832.07 |
Abbott India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 13,882 | 680,912 | 49.05 |
| Week | 9,537 | 419,359 | 43.97 |
| 1 Month | 10,449 | 441,157 | 42.22 |
| 6 Month | 16,502 | 787,988 | 47.75 |
Abbott India Result Highlights
Abbott India Synopsis
NSE-Medical-Diversified
Abbott India Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4919.27 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2022. Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330.| Market Cap | 45,668 |
| Sales | 5,265 |
| Shares in Float | 0.53 |
| No of funds | 71 |
| Yield | 0.67 |
| Book Value | 16.2 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | |
| Alpha | 0.11 |
| Beta | 0.4 |
Abbott India
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 74.99% | 74.99% | 74.99% | |
| Mutual Funds | 6.41% | 5.67% | 4.84% | |
| Insurance Companies | 1.84% | 2.04% | 0.32% | |
| Foreign Portfolio Investors | 0.2% | 0.2% | 0.2% | |
| Financial Institutions/ Banks | 0.02% | 0.02% | 0.08% | |
| Individual Investors | 14.25% | 14.6% | 14.72% | |
| Others | 2.29% | 2.48% | 4.85% |
Abbott India Management
| Name | Designation |
|---|---|
| Mr. Munir Shaikh | Chairman |
| Mr. Vivek V Kamath | Managing Director |
| Mr. Rajiv Sonalker | WholeTime Director & CFO |
| Mr. Kaiyomarz Marfatia | Non Executive Director |
| Mr. Ambati Venu | Non Executive Director |
| Mr. Sabina Ewing | Non Executive Director |
| Mr. Sudarshan Jain | Independent Director |
| Ms. Anisha Motwani | Independent Director |
| Ms. Shalini Kamath | Independent Director |
Abbott India Forecast
Price Estimates
Abbott India FAQs
What is Share Price of Abbott India ?
Abbott India share price is ₹21481 As on 23 March, 2023 | 06:11
What is the Market Cap of Abbott India ?
The Market Cap of Abbott India is ₹45647.6 Cr As on 23 March, 2023 | 06:11
What is the P/E ratio of Abbott India ?
The P/E ratio of Abbott India is 49.1 As on 23 March, 2023 | 06:11
What is the PB ratio of Abbott India ?
The PB ratio of Abbott India is 16.2 As on 23 March, 2023 | 06:11